| Nina Novakovic, | |
|
604 W Warner Rd Ste E101, Chandler, AZ 85225-2909 | |
| (480) 775-4700 | |
| Not Available |
| Full Name | Nina Novakovic |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 6 Years |
| Location | 604 W Warner Rd Ste E101, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124503909 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 7197 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Petar N Novakovic Md Pc | 6305841891 | 5 |
News Archive
Vaccine manufacturers and public health decision-makers need to collaborate in a more efficient and effective manner not only to reduce the likelihood of supply shortages for pediatric vaccines but also to maximize community immunity by using vaccine doses to increase coverage, according to research published by a University of Illinois researcher who specializes in statistics and data analysis.
Antibody-mediated rejection of the transplanted heart is a recognized clinical complication and a major limitation to survival of patients who have undergone heart transplantation. Experts have now developed a new working formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection.
Researchers from the Sackler Center at Weill Cornell Medical College have designed a new class of drugs that targets BCL6, a master regulatory protein responsible for causing the most common type of non-Hodgkin's lymphoma.
New research released today finds that pain affects the majority of Kentuckians, yet most underestimate its severity and the need for effective treatment. The survey by the American Osteopathic Association (AOA) uncovered that nearly three in five Kentuckians believe pain is just a part of life and two in five don't believe it can be eased with proper treatment.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched levalbuterol inhalation solution USP (Concentrate), 0.25%, (1.25 mg/0.5 mL). Mylan, which has already launched the product, will market this product with 180 days of exclusivity.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nina Novakovic, 77 S Presidio Dr, Gilbert, AZ 85233-4766 Ph: () - | Nina Novakovic, 604 W Warner Rd Ste E101, Chandler, AZ 85225-2909 Ph: (480) 775-4700 |
News Archive
Vaccine manufacturers and public health decision-makers need to collaborate in a more efficient and effective manner not only to reduce the likelihood of supply shortages for pediatric vaccines but also to maximize community immunity by using vaccine doses to increase coverage, according to research published by a University of Illinois researcher who specializes in statistics and data analysis.
Antibody-mediated rejection of the transplanted heart is a recognized clinical complication and a major limitation to survival of patients who have undergone heart transplantation. Experts have now developed a new working formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection.
Researchers from the Sackler Center at Weill Cornell Medical College have designed a new class of drugs that targets BCL6, a master regulatory protein responsible for causing the most common type of non-Hodgkin's lymphoma.
New research released today finds that pain affects the majority of Kentuckians, yet most underestimate its severity and the need for effective treatment. The survey by the American Osteopathic Association (AOA) uncovered that nearly three in five Kentuckians believe pain is just a part of life and two in five don't believe it can be eased with proper treatment.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched levalbuterol inhalation solution USP (Concentrate), 0.25%, (1.25 mg/0.5 mL). Mylan, which has already launched the product, will market this product with 180 days of exclusivity.
› Verified 8 days ago
Sarah Wilson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 485 S Dobson Rd Ste 201, Chandler, AZ 85224 Phone: 480-728-4981 Fax: 480-728-4985 | |
Carol B Brennan, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 475 S Dobson Rd, Chandler, AZ 85224 Phone: 480-728-3753 Fax: 480-728-3305 | |
Alicia Lynn Burns, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 333 N Dobson Rd Ste 15, Chandler, AZ 85224 Phone: 480-282-8336 | |
Emily Montague, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2055 W Frye Rd Ste 9, Chandler, AZ 85224 Phone: 480-821-3600 | |
Mr. Finley Chow, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1343 N Alma School Rd Ste 205, Chandler, AZ 85224 Phone: 480-963-1853 | |
David Rios, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2201 W Fairview St Ste 9, Chandler, AZ 85224 Phone: 480-470-4000 | |
Michelle T. Harbottle, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 811 S Hamilton St, Chandler, AZ 85225 Phone: 480-344-6100 Fax: 480-344-6101 |